Meanwhile, brain and bone metastasis were less prevalent in patients classified into YAP1 subtype than those with ASCL1 subtype, respectively, and liver metastasis was decreased in YAP1 subtype than NEUROD1 subtype. This evidence concerns the gene ASCL1 and bone metastasis.